Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATAMIS: Clopidogrel plus Aspirin in Acute Mild-Moderate Ischemic Stroke
NCT02869009Phase 3Completed
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Nov 2016
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel in ischemic stroke, sponsored by General Hospital of the Northern Theater Command. Started Nov 2016; status: completed.
02
Drugs
clopidogrel
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02869009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02869009.